An Intermediate Size Expanded Access Protocol of AMX0035 for ALS
Clinical trial NCT05286372 · APPROVED_FOR_MARKETING
Trial details
- NCT number
- NCT05286372
- Sponsor
- Amylyx Pharmaceuticals Inc.
- Status
- APPROVED_FOR_MARKETING
- Study type
- EXPANDED_ACCESS
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.